Director/PDMR Shareholding

GSK

Wed 15:30

RNS Number : 7545H
  
GSK PLC
  
10 June 2026
  
 


 
GSK plc (the 'Company')
Transaction notification
​





1.


Details of PDMR/person closely associated with them ('PCA')




a)


Name


Maya Martinez-Davis




b)


Position/status


President, US




c)


Initial notification/
amendment


Initial notification




2.


Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor




a)


Name


GSK plc




b)


LEI


5493000HZTVUYLO1D793




3.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted




a)


Description of the financial instrument


American Depositary Shares ('ADS')
 
ISIN: US37733W2044




b)


Nature of the transaction


Acquisition of notional ADS within Ms Martinez-Davis's GSK Executive Supplemental Savings Plan account
 




c)


Price(s) and volume(s)






Price(s)


Volume(s)












$50.6400


9.4289


























d)


Aggregated information
 
 


N/A (single transaction)




Aggregated volume Price








e)


Date of the transaction


2026-06-08




f)


Place of the transaction
 


New York Stock Exchange (XNYS)




 
 
About GSK
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.
 
Registered in England & Wales:
No. 3888792
 
Registered Office:
79 New Oxford Street
London
WC1A 1DG
 
 
 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHSFUSASEMSEEM